Skip to main content
Top
Published in: Pathology & Oncology Research 4/2008

01-12-2008 | Original Paper

Seasonal Variation of Childhood Acute Lymphoblastic Leukaemia is Different Between Girls and Boys

Authors: Tibor A. Nyári, Pál Kajtár, Katalin Bartyik, László Thurzó, Richard McNally, Louise Parker

Published in: Pathology & Oncology Research | Issue 4/2008

Login to get access

Abstract

The aim of this study was to investigate seasonal trends in the incidence of acute lymphoblastic leukaemia (ALL) around the times of birth and diagnosis in children aged 0–4 years and also to examine gender specific effects. Children born in South Hungary during 1981–1997 were analysed. Registrations of first malignancies for children, diagnosed under age 5 years before the end of 2002 were obtained from the Hungarian Paediatric Oncology Group providing a representative sample of Hungarian children over a 17 year period of time. Data were available on the corresponding numbers of births for each month of the study period were obtained. Statistical analyses were performed using logistic regression with harmonic components. The study analysed 121 cases of children, aged under 5 years, who were diagnosed with ALL. We found no seasonal effect related to date of diagnosis. However, there was seasonal variability for ALL related to date of birth. Maximal rates were seen in children born in February and August in the simple harmonic regression model for all children diagnosed with ALL. Analysis by gender found evidence of seasonality related to month of birth with peaks in February and August in boys, but different seasonal effects were seen for girls (peak in November, nadir in May). Our study provides some evidence that male specific immune responses to infections around the time of birth could explain the male predominance in the incidence of ALL.
Literature
1.
go back to reference Alexander FE, Boyle P, Carli PM et al (1998) Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Brit J Cancer 77:812–817PubMed Alexander FE, Boyle P, Carli PM et al (1998) Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Brit J Cancer 77:812–817PubMed
3.
go back to reference Knox EG, Gilman EA (1997) Hazard proximities of childhood cancers in Great Britain from 1953–80. J Epidemiol Comm Health 51:151–159CrossRef Knox EG, Gilman EA (1997) Hazard proximities of childhood cancers in Great Britain from 1953–80. J Epidemiol Comm Health 51:151–159CrossRef
4.
go back to reference McNally RJQ, Eden TOB (2004) An infectious aetiology for childhood leukaemia: a review of the evidence. Brit J Haematol 127:243–263CrossRef McNally RJQ, Eden TOB (2004) An infectious aetiology for childhood leukaemia: a review of the evidence. Brit J Haematol 127:243–263CrossRef
5.
go back to reference Thorne R, Hunt LP, Mott MG (1998) Seasonality in the diagnosis of childhood acute lymphoblastic leukaemia. Brit J Cancer 77:678PubMed Thorne R, Hunt LP, Mott MG (1998) Seasonality in the diagnosis of childhood acute lymphoblastic leukaemia. Brit J Cancer 77:678PubMed
6.
go back to reference Nyari TA, Kajtar P, Bartyik K, Thurzo L, Parker L (2006) Childhood acute lymphoblastic leukaemia in relation to population mixing around the time of birth in South Hungary. Pediatric Blood Cancer 47:944–948PubMedCrossRef Nyari TA, Kajtar P, Bartyik K, Thurzo L, Parker L (2006) Childhood acute lymphoblastic leukaemia in relation to population mixing around the time of birth in South Hungary. Pediatric Blood Cancer 47:944–948PubMedCrossRef
7.
go back to reference Jakab Zs, Balogh E, Kiss Cs, Oláh É (2002) Epidemiologic studies in a population-based childhood cancer registry in Northeast Hungary. Medical Pediatric Oncol 38:338–344CrossRef Jakab Zs, Balogh E, Kiss Cs, Oláh É (2002) Epidemiologic studies in a population-based childhood cancer registry in Northeast Hungary. Medical Pediatric Oncol 38:338–344CrossRef
8.
go back to reference Central Demographic Agency 1982–1998 Demographic yearbook Central Demographic Agency. Budapest Central Demographic Agency 1982–1998 Demographic yearbook Central Demographic Agency. Budapest
9.
go back to reference Stolwijk AM, Straatman H, Zielhuis GA (1999) Studying seasonality by using sine and cosine functions in regression analysis. J Epidemiol Community Health 53:235–238PubMedCrossRef Stolwijk AM, Straatman H, Zielhuis GA (1999) Studying seasonality by using sine and cosine functions in regression analysis. J Epidemiol Community Health 53:235–238PubMedCrossRef
10.
go back to reference Kajtar P, Fazekasne KM, Mehes K (2003) Month of birth in childhood acute lymphoblastic leukemia. Orv Hetil 144:1869–1871PubMed Kajtar P, Fazekasne KM, Mehes K (2003) Month of birth in childhood acute lymphoblastic leukemia. Orv Hetil 144:1869–1871PubMed
11.
go back to reference Westerbeek RM, Blair V, Eden OB et al (1998) Seasonal variation in the onset of childhood leukemia and lymphoma. Brit J Cancer 78:119–124PubMed Westerbeek RM, Blair V, Eden OB et al (1998) Seasonal variation in the onset of childhood leukemia and lymphoma. Brit J Cancer 78:119–124PubMed
12.
go back to reference Badrinath P, Day NE, Stockton D (1997) Seasonality in the diagnosis of acute lymphocytic leukaemia. Brit J Cancer 75:1711–1713PubMed Badrinath P, Day NE, Stockton D (1997) Seasonality in the diagnosis of acute lymphocytic leukaemia. Brit J Cancer 75:1711–1713PubMed
13.
go back to reference Ross JA, Severson RK, Swensen AR et al (1999) Seasonal variations in the diagnosis of childhood cancer in the United States. Brit J Cancer 81:549–553PubMedCrossRef Ross JA, Severson RK, Swensen AR et al (1999) Seasonal variations in the diagnosis of childhood cancer in the United States. Brit J Cancer 81:549–553PubMedCrossRef
14.
go back to reference Karimi M, Yarmohammadi H (2003) Seasonal variations in the onset of childhood leukemia/lymphoma: April 1996 to March 2000, Shiraz, Iran. Hematol Oncol 21:51–55PubMedCrossRef Karimi M, Yarmohammadi H (2003) Seasonal variations in the onset of childhood leukemia/lymphoma: April 1996 to March 2000, Shiraz, Iran. Hematol Oncol 21:51–55PubMedCrossRef
15.
go back to reference Sorensen HT, Olsen JH, Rothman KJ (2001) Seasonal variation in month of birth and diagnosis of early childhood acute lymphoblastic leukemia. JAMA 285:168–169PubMedCrossRef Sorensen HT, Olsen JH, Rothman KJ (2001) Seasonal variation in month of birth and diagnosis of early childhood acute lymphoblastic leukemia. JAMA 285:168–169PubMedCrossRef
16.
go back to reference Feltbower RG, Pearce MS, Dickinson HO et al (2001) Seasonality of birth for cancer in Northern England, UK. Paediatric Perinatal Epidemiol 15:338–345CrossRef Feltbower RG, Pearce MS, Dickinson HO et al (2001) Seasonality of birth for cancer in Northern England, UK. Paediatric Perinatal Epidemiol 15:338–345CrossRef
17.
go back to reference Higgins CD, dos-Santos-Silva I, Stiller CA, Swerdlow AJ (2001)Season of birth and diagnosis of children with leukaemia: an analysis of over 15 000 UK cases occurring from 1953–95. Brit J Cancer 84:406–412PubMedCrossRef Higgins CD, dos-Santos-Silva I, Stiller CA, Swerdlow AJ (2001)Season of birth and diagnosis of children with leukaemia: an analysis of over 15 000 UK cases occurring from 1953–95. Brit J Cancer 84:406–412PubMedCrossRef
18.
go back to reference Lopman BA, Reacher M et al (2003) A summertime peak of “winter vomiting disease": surveillance of noroviruses in England and Wales, 1995 to 2002. BMC Public Health 3:13PubMedCrossRef Lopman BA, Reacher M et al (2003) A summertime peak of “winter vomiting disease": surveillance of noroviruses in England and Wales, 1995 to 2002. BMC Public Health 3:13PubMedCrossRef
19.
go back to reference Green MS (1992) The male predominance in the incidence of infectious diseases in children: a postulated explanation for disparities in the literature. Int J Epidemiol 21:381–386PubMedCrossRef Green MS (1992) The male predominance in the incidence of infectious diseases in children: a postulated explanation for disparities in the literature. Int J Epidemiol 21:381–386PubMedCrossRef
20.
go back to reference Schlegel RJ, Bellatrti JA (1969) Increased susceptibility of males to infection. Lancet ii:826–827CrossRef Schlegel RJ, Bellatrti JA (1969) Increased susceptibility of males to infection. Lancet ii:826–827CrossRef
21.
go back to reference Peltola H (1982) Observations on the seasonal variation of the most common acute pediatric diseases in the Helsinki area (Finland). J Comm Health 7:159–170CrossRef Peltola H (1982) Observations on the seasonal variation of the most common acute pediatric diseases in the Helsinki area (Finland). J Comm Health 7:159–170CrossRef
22.
go back to reference Dorak MT, Oguz FS, Yalman N et al (2002) A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. Leuk Res 26:651–656PubMedCrossRef Dorak MT, Oguz FS, Yalman N et al (2002) A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. Leuk Res 26:651–656PubMedCrossRef
23.
go back to reference Kinlen LJ (1995) Epidemiological evidence for an infective basis in childhood leukaemia. Brit J Cancer 71:1–5PubMed Kinlen LJ (1995) Epidemiological evidence for an infective basis in childhood leukaemia. Brit J Cancer 71:1–5PubMed
Metadata
Title
Seasonal Variation of Childhood Acute Lymphoblastic Leukaemia is Different Between Girls and Boys
Authors
Tibor A. Nyári
Pál Kajtár
Katalin Bartyik
László Thurzó
Richard McNally
Louise Parker
Publication date
01-12-2008
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 4/2008
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-008-9017-0

Other articles of this Issue 4/2008

Pathology & Oncology Research 4/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine